Additive Effects of Pravastatin and Valsartan.

Trial Profile

Additive Effects of Pravastatin and Valsartan.

Phase of Trial: Phase IV

Latest Information Update: 17 Jul 2013

At a glance

  • Drugs Pravastatin (Primary) ; Valsartan (Primary)
  • Indications Hypercholesterolaemia; Hypertension
  • Focus Biomarker; Therapeutic Use
  • Most Recent Events

    • 17 Jul 2013 Results published in the Diabetes.
    • 11 Mar 2013 Results with focus on metabolic response presented at the 62nd Annual Scientific Session of the American College of Cardiology.
    • 07 Nov 2012 Primary endpoint 'Flow-mediated-dilation' has been met.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top